These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18552311)

  • 1. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of positron emission tomography for lung cancer staging.
    Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
    Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.
    Hany TF; Steinert HC; Goerres GW; Buck A; von Schulthess GK
    Radiology; 2002 Nov; 225(2):575-81. PubMed ID: 12409597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
    Webb WR; Gatsonis C; Zerhouni EA; Heelan RT; Glazer GM; Francis IR; McNeil BJ
    Radiology; 1991 Mar; 178(3):705-13. PubMed ID: 1847239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of 18F-fluorodeoxyglucose positron emission tomography imaging in staging of non-small cell lung cancer].
    Guan Y; He S; Dong J
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1180-3. PubMed ID: 11769705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
    Bury T; Dowlati A; Paulus P; Corhay JL; Hustinx R; Ghaye B; Radermecker M; Rigo P
    Eur Respir J; 1997 Nov; 10(11):2529-34. PubMed ID: 9426090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of Pet-18FDG in lung cancer].
    Richter JA; Torre W; Gámez C; Aramendia JM; Crespo A; Nicolás A; Brugarolas A
    Med Clin (Barc); 1999 Nov; 113(15):567-71. PubMed ID: 10605681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma.
    Kernstine KH; Stanford W; Mullan BF; Rossi NP; Thompson BH; Bushnell DL; McLaughlin KA; Kern JA
    Ann Thorac Surg; 1999 Sep; 68(3):1022-8. PubMed ID: 10510001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET in lung cancer staging.
    Coleman RE
    Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer.
    Dunagan D; Chin R; McCain T; Case L; Harkness B; Oaks T; Haponik E
    Chest; 2001 Feb; 119(2):333-9. PubMed ID: 11171706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
    Schmid RA; Hillinger S; Bruchhaus H; Steinert HC; von Schulthess GK; Largiadèr F; Weder W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1264-7. PubMed ID: 9931854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
    Saunders CA; Dussek JE; O'Doherty MJ; Maisey MN
    Ann Thorac Surg; 1999 Mar; 67(3):790-7. PubMed ID: 10215230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer. Radiologic staging.
    Thoeni RF
    Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.
    Kim K; Park SJ; Kim BT; Lee KS; Shim YM
    Ann Thorac Surg; 2001 Jan; 71(1):290-4. PubMed ID: 11216764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer.
    Changlai SP; Tsai SC; Chou MC; Ho YJ; Kao CH
    Oncol Rep; 2001; 8(2):337-9. PubMed ID: 11182051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell lung cancer: staging with MR imaging.
    Jelinek JS; Redmond J; Perry JJ; Burrell LM; Benedikt RA; Geyer CA; Peller PJ; Wacks LL; Wise BJ; Ghaed VN
    Radiology; 1990 Dec; 177(3):837-42. PubMed ID: 2173844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
    Bury T; Dowlati A; Paulus P; Hustinx R; Radermecker M; Rigo P
    Eur J Nucl Med; 1996 Feb; 23(2):204-6. PubMed ID: 8925857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax.
    Patz EF; Erasmus JJ; McAdams HP; Connolly JE; Marom EM; Goodman PC; Leder RA; Keogan MT; Herndon JE
    Radiology; 1999 Jul; 212(1):56-60. PubMed ID: 10405720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
    Yap CS; Schiepers C; Fishbein MC; Phelps ME; Czernin J
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1166-73. PubMed ID: 12192561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.